佰睿壹新闻 Bio-Reinno News
2025年11月5日
November 5, 2025
佰睿壹生物亮相第16届World ADC大会，MCLICK™平台突破定点偶联技术瓶颈
BioReinno Unveils MCLICK™ Platform at 16th World ADC Conference, Breaking
Through Site-Specific Conjugation Bottlenecks
11月5日，佰睿壹生物CSO吉傲博士参加第16届 World ADC SAN DIEGO 大会，发表了题为《Versatile Conjugation
Platform:
MCLICK》的主题演讲。吉傲博士向全球业界详尽展示了公司自主研发的MCLICK™平台，这是一种不仅具备高度定点特异性，更兼顾成本效益与开发灵活性的通用型偶联技术。
On November 5th, Dr. Ao Ji, CSO of BioReinno, participated in the 16th World ADC SAN DIEGO Conference and delivered a keynote speech titled “Versatile Conjugation Platform: MCLICK.” Dr. Ji intruduced the company's independently developed MCLICK™ platform to the global industry. This is a versatile conjugation technology that not only offers high site-specificity but also balances cost-effectiveness and development flexibility.
On November 5th, Dr. Ao Ji, CSO of BioReinno, participated in the 16th World ADC SAN DIEGO Conference and delivered a keynote speech titled “Versatile Conjugation Platform: MCLICK.” Dr. Ji intruduced the company's independently developed MCLICK™ platform to the global industry. This is a versatile conjugation technology that not only offers high site-specificity but also balances cost-effectiveness and development flexibility.
阅读更多
Read More
2025年4月24日
April 24, 2025
药明合联与苏州佰睿壹达成战略技术合作，共同赋能下一代ADC创新研发
Global Strategic Technology Collaboration with WUXI XDC
全球领先的生物偶联药物CRDMO药明合联与专注于化学定点偶联技术创新的佰睿壹生物达成战略技术合作，共同加速下一代抗体偶联药物的开发进程...
Leading bioconjugate drug CRDMO WuXi XDC and Bio-Reinnovation, focused on
chemical site-specific conjugation technology innovation, reach strategic technology
collaboration...
阅读更多
Read More
2024年3月15日
March 15, 2024
佰睿壹生物在World ADC会议上发布最新偶联技术壁报
Bio-Reinno Presents Latest Conjugation Technology Poster at World ADC
Conference
佰睿壹生物在美国旧金山举办的World
ADC会议上，发布了公司最新的ADC偶联技术壁报，展示了MCLICK平台在多载荷ADC制备和工艺优化方面的最新进展...
Bio-Reinno presented the company's latest ADC conjugation technology poster
at the World ADC Conference in San Francisco, showcasing MCLICK platform's latest
progress in multi-payload ADC preparation and process optimization...
阅读更多
Read More
佰睿壹出版物及IP Bio-Reinno Publications & IP
已申请7项PCT专利。未来12个月将有更多双载荷及多载荷ADC相关专利申请。
7 PCT patents filed. More patents for dual-payload and multi-payload ADCs will
be filed in future 12 Month.
我们正在准备发布更多关于ADC技术平台和药物开发的研究成果，敬请期待...
We are preparing to publish more research findings on ADC technology platform
and drug development, stay tuned...
敬请期待
Stay Tuned